Utama › Gangguan Tidur › Florida
Kajian klinikal Gangguan Tidur di Florida
6 kajian untuk Gangguan Tidur sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- dan 5 lagi
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07598708A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07823608A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Maimi
- Alkermes Investigational Site, Winter Park
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07540897A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06767683Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.